What is COPD?
COPD is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases 1.
Core Definition
COPD represents a chronic inflammatory lung condition that causes progressive breathing difficulties. The disease involves structural damage to both the airways (bronchiolitis) and lung tissue (emphysema), resulting in airflow obstruction that is not fully reversible 1.
Key Clinical Features
Symptoms:
- Dyspnea (shortness of breath) - the most characteristic symptom, causing major disability and anxiety
- Chronic cough - often the first symptom, frequently dismissed by patients as a consequence of smoking
- Sputum production - regular production for 3+ months in 2 consecutive years defines chronic bronchitis
- Wheezing and chest tightness that varies day-to-day 1
In severe disease, patients develop fatigue, weight loss, and anorexia 1.
Diagnosis Requirements
Spirometry is mandatory to confirm the diagnosis - a post-bronchodilator FEV1/FVC ratio less than 0.70 confirms persistent airflow limitation 1. Physical examination alone is rarely diagnostic, as physical signs typically don't appear until lung function is significantly impaired 1.
Major Risk Factors
Tobacco smoking is the primary risk factor, but COPD is not exclusively a smoker's disease 1:
- Cigarette smoking - most well-studied risk factor
- Occupational exposures - organic/inorganic dusts, chemical agents, fumes (underappreciated)
- Biomass fuel exposure - wood, animal dung, crop residues burned in poorly ventilated dwellings
- Air pollution - both indoor and outdoor
- Genetic factors - alpha-1-antitrypsin deficiency (rare)
- Childhood factors - severe respiratory infections, abnormal lung development, in utero exposures
- Asthma - may predispose to chronic airflow limitation
- HIV and tuberculosis - accelerate COPD development 1
Approximately 50% of COPD cases develop from accelerated lung function decline, while the other 50% result from abnormal lung growth and development 1.
Disease Characteristics
COPD is progressive and punctuated by exacerbations (acute worsening of respiratory symptoms) 1. The disease is associated with significant comorbid conditions that independently affect mortality and hospitalizations 1.
Important caveat: Chronic respiratory symptoms may exist in individuals with normal spirometry, and smokers without airflow limitation can have structural lung disease (emphysema, airway wall thickening, gas trapping) 1.
Global Burden
COPD is the third leading cause of death worldwide and represents a substantial economic burden, with total costs in the US estimated at $49.9 billion in 2010 2. The disease affects more than 5% of the adult population in the United States, with global prevalence estimated at 10.3% among people aged 30-79 years (391.9 million people), with 80.5% living in low- and middle-income countries 3.